文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

白细胞介素-8促成肿瘤浸润中性粒细胞的功能多样性：癌症免疫治疗的新靶点。

IL-8 contributes to functional diversity of tumor-infiltrating neutrophils: A new target for cancer immunotherapy.

作者信息

Tavukcuoglu Ece, Esendagli Gunes

机构信息

Hacettepe University Cancer Institute, Department of Basic Oncology, Ankara, Türkiye.

Hacettepe University Cancer Institute, Department of Basic Oncology, Ankara, Türkiye.

出版信息

Dev Cell. 2025 Feb 3;60(3):339-341. doi: 10.1016/j.devcel.2025.01.003.

DOI:10.1016/j.devcel.2025.01.003
PMID:39904319
Abstract

In this issue of Developmental Cell, Tang et al. identify CD74 neutrophils as a subpopulation promoted by IL-8 in the tumor microenvironment of non-small lung cancer (NSCLC). These CD74 neutrophils support anti-tumor T cell responses and enhance the efficacy of anti-PD-1 immunotherapy and targeted therapy in NSCLC.

摘要

在本期《发育细胞》杂志中，唐等人将CD74阳性中性粒细胞鉴定为非小细胞肺癌（NSCLC）肿瘤微环境中由白细胞介素-8促进的一个亚群。这些CD74阳性中性粒细胞支持抗肿瘤T细胞反应，并增强NSCLC中抗PD-1免疫疗法和靶向疗法的疗效。

相似文献

[1]
IL-8 contributes to functional diversity of tumor-infiltrating neutrophils: A new target for cancer immunotherapy.

Dev Cell. 2025-2-3

[2]
A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression.

Dev Cell. 2025-2-3

[3]
Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC.

Trends Cancer. 2024-5

[4]
Tumor treating fields enhance anti-PD therapy by improving CCL2/8 and CXCL9/CXCL10 expression through inducing immunogenic cell death in NSCLC models.

BMC Cancer. 2025-3-17

[5]
Interleukin-33, a Potential Cytokine Expressed in Tumor Microenvironment Involves in Antitumor Immunotherapy Through Facilitates CD8 T Cells.

J Interferon Cytokine Res. 2018-11

[6]
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.

BMC Cancer. 2021-1-5

[7]
PD-1/PD-L1 interaction score and NKT-like cell infiltration predict immunotherapy efficacy in non-small cell lung cancer patients.

Cytotherapy. 2024-12

[8]
Lung cancer: potential targets for immunotherapy.

Lancet Respir Med. 2013-8-23

[9]
Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges.

Front Immunol. 2024-4-9

[10]
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy.

Front Immunol. 2025-2-10

引用本文的文献

[1]
Bibliometric and visualized analysis of global distribution and research frontiers in tumor immune escape.

Front Immunol. 2025-6-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索